Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04599205

Unknown

Evaluation of Laser and Tranexamic Acid in Treatment of Melasma

Melasma
NCT02435732

Unknown

CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60%

Kidney Failure
NCT04389554

Completed

D-dimer Levels in Pregnant With COVID-19

COVID-19 | D-dimer
NCT04303130

Unknown

Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC

Non-small Cell Lung Cancer
NCT00655668

Terminated

A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma (EXPECT)

T-cell Non-Hodgkin's Lymphoma
NCT02665689

Terminated

Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab (DORO)

Macular Edema, Cystoid | Visual Acuity Reduced Transiently
NCT02321839

Completed

Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular AMD.

Neovascular Age-related Macular Degeneration
NCT03974425

Completed

One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab

Diabetic Macular Edema
NCT00348595

Completed

Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer

Prostate Cancer
NCT02107131

Completed

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab (ERASER)

Diabetic Macular Edema
NCT03452657

Unknown

Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)

Diabetic Retinopathy | Ranibizumab
NCT02018523

Terminated

Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung
NCT03280212

Unknown

Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma (TRACE)

Chronic Subdural Hematoma
NCT00016549

Completed

Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer

Breast Cancer
NCT00379795

Completed

An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO

Choroidal Neovascularization, Age-related Macular Degeneration
NCT01750762

Terminated

Lenalidomide After Allo Transplant

Lymphoma | Multiple Myeloma
NCT00856661

Terminated

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

Stroke
NCT01641549

Unknown

Surgery Versus Fibrinolytic Therapy for Left-sided Prosthetic Heart Valve Thrombosis (SAFE-PVT)

Left-sided Prosthetic Heart Valve Thrombosis
NCT00109005

Completed

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Melanoma
NCT00826371

Completed

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients (EXTEND II)

Age Related Macular Degeneration
NCT02933905

Completed

Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Diabetic Macular Edema | Vitreomacular Interface | Anti-VEGF Treatment
NCT00779922

Completed

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

Multiple Myeloma | Impaired Renal Function
NCT02914626

Unknown

Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study

Glaucoma, Neovascular | Ranibizumab
NCT02842294

Unknown

Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer (COBEQOL)

Quality of Life | Metastatic Colorectal Cancer
NCT01235260

Completed

Becaplermin Use and Cancer Risk in a Patient Population of U.S. Veterans With Diabetes

Diabetes Mellitus | Diabetic Foot | Foot Ulcer | Diabetic Neuropathies
NCT01981863

Completed

Fibrinolysis Before Cardiopulmonary Bypass?

Pathologic Fibrinolysis
NCT01918878

Unknown

Aflibercept (EYLEA)as Secondary or Third Line Treatment for Neovascular Age-related Macular Degeneration.

Neovascular Age-related Macular Degeneration
NCT01246076

Completed

Lenalidomide for Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Myelodysplastic Syndromes
NCT01014975

Completed

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Acute Ischemic Stroke
NCT01180569

Withdrawn

Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma

Lymphoma | Follicular Lymphoma
NCT00139360

Completed

Efficacy of Bevacizumab Monotherapy in Treatment of Metastatic Melanoma

Metastatic Melanoma
NCT00424710

Completed

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL)

Polypoidal Choroidal Vasculopathy
NCT01135914

Completed

Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) (RESPOND)

Diabetic Macular Edema
NCT01002092

Unknown

A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma

Osteosarcoma
NCT02182011

Completed

A Study to Investigate the Procoagulant Effect of Tenecteplase (TNK-tPA), Alteplase (Rt-PA) and Streptokinase (SK) Administered to Patients With Acute Myocardial Infarction (AMI)

Myocardial Infarction
NCT02152917

Unknown

Comparison of Floseal® and Tranexamic Acid on Bleeding Control After Total Knee Arthroplasty

Knee Osteoarthritis
NCT01258010

Completed

Impact of Tranexamic Acid on Red Blood Cell Transfusion in Spinal Surgery

Orthopedic Surgery | Neurosurgery | Red Blood Cell Transfusion
NCT00533520

Completed

Evaluation of Dosing Interval of Higher Doses of Ranibizumab (BGB/IST)

Macular Degeneration | Choroidal Neovascularization
NCT00090623

Completed

A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)

Macular Degeneration
NCT01824043

Unknown

Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage

Diabetic Retinopathy | Vitreous Hemorrhage
NCT01820962

Terminated

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Thrombosis | Bacteremia | Hematological Malignancies
NCT00004229

Completed

Endostatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
NCT01736449

Completed

Role of Sub-Conjunctival Bevacizumab in Post Pterygium Excision Management

Pterygium
NCT01676506

Unknown

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration
NCT00373659

Completed

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Neovascular Age-related Macular Degeneration
NCT00841581

Completed

Lucentis to Treat Pigment Epithelial Detachment

Pigment Epithelial Detachment
NCT00797303

Completed

The Effect of Bevacizumab on Corneal Neovascularization (BQ-1-08-ARVO)

Corneal Neovascularization
NCT01189526

Unknown

Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

Branch Retinal Vein Occlusion
NCT00446472

Unknown

Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers

Diabetic Foot Ulcers
NCT00165568

Completed

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations